Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and Hormone-Dependent Neoplasms

4-butyrolactone has been researched along with Hormone-Dependent Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nijmeijer, SM; Ruchirawat, S; van den Berg, M; van Duursen, MB1
Abrahamsson, A; Dabrosin, C; Lindahl, G; Saarinen, N1
Bova, GS; Han, WF; Nelson, JB; Pflug, BR; Pizer, ES; Udan, MS1

Other Studies

3 other study(ies) available for 4-butyrolactone and Hormone-Dependent Neoplasms

ArticleYear
Chemopreventive actions by enterolactone and 13 VIOXX-related lactone derivatives in H295R human adrenocortical carcinoma cells.
    Toxicology letters, 2010, Feb-15, Volume: 192, Issue:3

    Topics: 4-Butyrolactone; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Cell Cycle; Cell Line, Tumor; Enzyme Induction; Flavonoids; Gene Expression; Humans; Lactones; Lignans; Mitogen-Activated Protein Kinase Kinases; Neoplasms, Hormone-Dependent; Phytoestrogens; Protein Processing, Post-Translational; Steroid 17-alpha-Hydroxylase; Structure-Activity Relationship; Sulfones

2010
Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
    Cancer research, 2011, Jan-01, Volume: 71, Issue:1

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Cell Line, Tumor; Estrogen Receptor alpha; Estrogens; Female; Flax; Humans; Immunohistochemistry; Interleukin 1 Receptor Antagonist Protein; Lignans; Macrophages; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Stromal Cells; Tamoxifen

2011
Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression.
    The Prostate, 2001, May-01, Volume: 47, Issue:2

    Topics: 4-Butyrolactone; Androgens; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Blotting, Western; Chromatography, Thin Layer; Enzyme Inhibitors; Fatty Acid Synthases; Humans; Immunohistochemistry; Lipids; Male; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Random Allocation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001